AC Immune shows first brain images of TDP-43 pathology in phase 1 trial
Tweet Send to a Friend
AC Immune SA (NASDAQ: ACIU) presented initial data from its Phase 1 trial of PET tracer ACI-19626, showing the first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
